A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide
We report herein that under our experimental conditions, TCH inhibits M. tuberculosis in solid but not in liquid medium, and that in spite of resembling Isoniazid and Ethionamide, it does not affect mycolic acid synthesis. To understand the mechanisms of action of TCH we isolated M. tuberculosis TCH resistant mutants which fell into two groups; one resistant to TCH and Isoniazid but not to Ethionamide or Triclosan, and the other resistant only to TCH with no, or marginal, cross resistance to Isoniazid.
Source: Tuberculosis - Category: Respiratory Medicine Authors: Jorgelina J. Franceschelli, Juan M. Belardinelli, Ping Tong, Brendan Loftus, Alejandro Recio-Balsells, Guillermo R. Labadi é, Stephen V. Gordon, Hector R. Morbidoni Tags: Drug Discovery and Resistance Source Type: research
More News: Respiratory Medicine | Tuberculosis